• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53蛋白具有3'至5'核酸外切酶活性。

p53 Protein exhibits 3'-to-5' exonuclease activity.

作者信息

Mummenbrauer T, Janus F, Müller B, Wiesmüller L, Deppert W, Grosse F

机构信息

Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie, Hamburg, Germany.

出版信息

Cell. 1996 Jun 28;85(7):1089-99. doi: 10.1016/s0092-8674(00)81309-4.

DOI:10.1016/s0092-8674(00)81309-4
PMID:8674115
Abstract

Highly purified p53 protein from different sources was able to degrade DNA with a 3'-to-5' polarity, yielding deoxynucleoside monophosphates as reaction products. This exonuclease activity was dependent on Mg2+ and inhibited by addition of 5 mM nucleoside monophosphates. This exonuclease activity is intrinsic to the wild-type p53 protein: it copurified with p53 during p53 preparation; only purified wild-type p53, but not identically purified mutant p53 proteins displayed exonuclease activity; the exonuclease activity could be reconstituted from SDS gel-purified and urea-renatured p53 protein and mapped to the core domain of the p53 molecule; and finally, purified p53 protein could be UV-cross-linked to GMP. A p53-intrinsic exonuclease activity should substantially extend our view on the role of p53 as a "guardian of the genome."

摘要

从不同来源高度纯化的p53蛋白能够以3'至5'的极性降解DNA,产生脱氧核苷单磷酸作为反应产物。这种核酸外切酶活性依赖于Mg2+,并受到5 mM核苷单磷酸添加的抑制。这种核酸外切酶活性是野生型p53蛋白所固有的:它在p53制备过程中与p53共纯化;只有纯化的野生型p53,而不是同样纯化的突变型p53蛋白显示出核酸外切酶活性;核酸外切酶活性可以从SDS凝胶纯化和尿素复性的p53蛋白中重构,并定位到p53分子的核心结构域;最后,纯化的p53蛋白可以与GMP进行紫外线交联。p53固有的核酸外切酶活性将极大地扩展我们对p53作为“基因组守护者”作用的认识。

相似文献

1
p53 Protein exhibits 3'-to-5' exonuclease activity.p53蛋白具有3'至5'核酸外切酶活性。
Cell. 1996 Jun 28;85(7):1089-99. doi: 10.1016/s0092-8674(00)81309-4.
2
Removal of anti-human immunodeficiency virus 2',3'-dideoxynucleoside monophosphates from DNA by a novel human cytosolic 3'-->5' exonuclease.一种新型人胞质3'→5'核酸外切酶从DNA中去除抗人免疫缺陷病毒2',3'-双脱氧核苷单磷酸
Biochem Pharmacol. 1995 Sep 7;50(6):815-21. doi: 10.1016/0006-2952(95)00205-e.
3
Dissection of the sequence-specific DNA binding and exonuclease activities reveals a superactive yet apoptotically impaired mutant p53 protein.对序列特异性DNA结合和核酸外切酶活性的剖析揭示了一种超活性但凋亡功能受损的突变型p53蛋白。
Cell Cycle. 2009 May 15;8(10):1603-15. doi: 10.4161/cc.8.10.8548.
4
[P53 delta 37 protein exhibits 3'-5' exonuclease activity].[P53 δ37蛋白具有3'-5'核酸外切酶活性]
Hua Xi Yi Ke Da Xue Xue Bao. 2000 Mar;31(1):21-3.
5
p53 in cytoplasm exerts 3'→5' exonuclease activity with dsRNA.细胞质中的 p53 具有双链 RNA 的 3'→5'外切核酸酶活性。
Cell Cycle. 2010 Jun 15;9(12):2442-55. doi: 10.4161/cc.9.12.12053.
6
Exonucleolytic degradation of RNA by p53 protein in cytoplasm.p53蛋白在细胞质中对RNA进行核酸外切酶降解。
J Mol Med (Berl). 2008 Jan;86(1):75-88. doi: 10.1007/s00109-007-0247-5. Epub 2007 Aug 15.
7
Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase alpha-primase.肿瘤抑制蛋白p53与DNA聚合酶α-引发酶的物理及功能相互作用。
Nucleic Acids Res. 2002 Apr 1;30(7):1493-9. doi: 10.1093/nar/30.7.1493.
8
The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.小鼠p53肿瘤抑制蛋白的N端是一个影响激活和热稳定性的独立调节结构域。
J Mol Biol. 1998 Jan 30;275(4):575-88. doi: 10.1006/jmbi.1997.1507.
9
Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding.杆状病毒重组野生型p53的特性。p53的二聚化是高亲和力DNA结合所必需的,并且半胱氨酸氧化会抑制p53与DNA的结合。
Eur J Biochem. 1994 Jul 15;223(2):683-92. doi: 10.1111/j.1432-1033.1994.tb19041.x.
10
Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding.p53核心结构域3'至5'核酸外切酶活性与序列特异性DNA结合的不同调控。
Mol Cell Biol. 1999 Mar;19(3):2155-68. doi: 10.1128/MCB.19.3.2155.

引用本文的文献

1
The Role of Tumor Suppressor p53 Protein in HIV-Host Cell Interactions.肿瘤抑制因子 p53 蛋白在 HIV-宿主细胞相互作用中的作用。
Cells. 2024 Sep 10;13(18):1512. doi: 10.3390/cells13181512.
2
Astaxanthin Induces Apoptosis in MCF-7 Cells through a p53-Dependent Pathway.虾青素通过 p53 依赖途径诱导 MCF-7 细胞凋亡。
Int J Mol Sci. 2024 Jun 28;25(13):7111. doi: 10.3390/ijms25137111.
3
Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance.p53 异构体的规范和非规范功能:增强肿瘤发展和治疗耐药性的复杂性。
Cell Death Dis. 2024 Jun 12;15(6):412. doi: 10.1038/s41419-024-06783-7.
4
The levels of p53 govern the hierarchy of DNA damage tolerance pathway usage.p53的水平决定了DNA损伤耐受途径使用的层级关系。
Nucleic Acids Res. 2024 Apr 24;52(7):3740-3760. doi: 10.1093/nar/gkae061.
5
Genomic instability and eye diseases.基因组不稳定与眼部疾病
Adv Ophthalmol Pract Res. 2023 Apr 5;3(3):103-111. doi: 10.1016/j.aopr.2023.03.002. eCollection 2023 Aug-Sep.
6
Exonucleases: Degrading DNA to Deal with Genome Damage, Cell Death, Inflammation and Cancer.核酸外切酶:降解 DNA 以应对基因组损伤、细胞死亡、炎症和癌症。
Cells. 2022 Jul 9;11(14):2157. doi: 10.3390/cells11142157.
7
p53 isoforms differentially impact on the POLι dependent DNA damage tolerance pathway.p53 异构体对 POLι 依赖性 DNA 损伤耐受途径有差异影响。
Cell Death Dis. 2021 Oct 13;12(10):941. doi: 10.1038/s41419-021-04224-3.
8
Frame-shift mediated reduction of gain-of-function p53 R273H and deletion of the R273H C-terminus in breast cancer cells result in replication-stress sensitivity.框移介导的功能获得性p53 R273H的减少以及乳腺癌细胞中R273H C末端的缺失导致复制应激敏感性。
Oncotarget. 2021 Jun 8;12(12):1128-1146. doi: 10.18632/oncotarget.27975.
9
How the Other Half Lives: What p53 Does When It Is Not Being a Transcription Factor.《另一半的生活:p53 作为转录因子之外的功能》
Int J Mol Sci. 2019 Dec 18;21(1):13. doi: 10.3390/ijms21010013.
10
Methods for Enhancing Clustered Regularly Interspaced Short Palindromic Repeats/Cas9-Mediated Homology-Directed Repair Efficiency.提高成簇规律间隔短回文重复序列/Cas9介导的同源定向修复效率的方法
Front Genet. 2019 Jun 17;10:551. doi: 10.3389/fgene.2019.00551. eCollection 2019.